282 results on '"Pittet V"'
Search Results
2. P860 The Costs of Inflammatory Bowel Diseases in High-Income Settings
3. Topical therapy is underused in patients with ulcerative colitis
4. Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)
5. Lessons from COVID-19 syndromic surveillance through emergency department activity: a prospective time series study from western Switzerland
6. P711 Vegetarian or gluten-free diet in patients with IBD – associated with lower psychological well-being and quality of life but no indication of beneficial effects on course of disease
7. P298 Comparison between clinical and patient-reported symptoms among Crohnʼs disease and ulcerative colitis patients
8. Development of appropriateness criteria for the surgical treatment of symptomatic lumbar degenerative spondylolisthesis (LDS)
9. Introduction and purpose
10. An introduction to Random Forests for modeling tasks - theory and practice in python with public health case studies
11. An overview of AI and Machine Learning methods: motivations, concepts, and examples
12. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohnʼs disease
13. SICOVID: un système cantonal d’information COVID pour la décision en santé publique [SICOVID: a cantonal COVID information system for public health decision-making]
14. The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohnʼs disease
15. Evolution of anaesthesia care and related events between 1996 and 2010 in Switzerland
16. Transient moisture effects on wood creep
17. Quality of life: a potentially useful measure to indicate subclinical flares in Crohn disease
18. P238 Natural history of perianal fistulizing Crohn’s disease in the Swiss IBD cohort
19. DOP40 Does levels of concerns and expectations predict IBD disease status?
20. P808 Prevalence and factors associated with sleep disturbances in inflammatory bowel disease patients compared with normal controls
21. P657 Evolution of Crohn’s disease progression and surgery rates over 10 years for patients who initiated biologic treatment early compared with late or no biologic initiation
22. Appropriateness of therapy for fistulizing Crohnʼs disease: findings from a national inflammatory bowel disease cohort
23. The occurrence of intra-operative hypotension varies between hospitals: observational analysis of more than 147,000 anaesthesia
24. Hypertension and intra-operative incidents: a multicentre study of 125 000 surgical procedures in Swiss hospitals
25. The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation
26. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)
27. P794 Fatigue in inflammatory bowel disease
28. P662 Remission to vedolizumab is not higher in TNF-naïve compared with TNF-pre-treated patients with Crohn’s disease
29. Mise au point sur la rectocolite ulcéro-hémorragique en 2017 [Management of ulcerative colitis in 2017]
30. P581 Patient-reported complementary and alternative medicine use in IBD: 10 years of observation among patients included in a national cohort
31. P855 Vegetarian and gluten-free diet in patients with IBD—associated with a different microbiota compared with omnivore IBD patients
32. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease
33. Systematic evaluation of clinical predictors of aggressive ulcerative colitis
34. Azathioprine and 6-Mercaptopurine use in the Swiss IBD cohort : adverse effects, causes of discontinuation and risk of 'flares' according to 6-TG levels
35. Prevalence of extraintestinal manifestations in paediatric patients with Inflammatory Bowel Disease : results from the Swiss IBD Cohort Study
36. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease
37. Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort
38. Process-driven design and piloting of a site-specific constructed wetland for copper and selenium treatment in the Yukon, Canada.
39. Evolution of anaesthesia care and related events between 1996 and 2010 in a developed country
40. Activité des services d'urgence dans le canton de Vaud: analyse rétrospective 2000-2010
41. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
42. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort
43. Normalization of EMG amplitude using manual muscle testing: Perspective in clinical gait analysis
44. Increasing prehospital emergency medical service interventions for nursing home residents
45. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals
46. Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness
47. Topical therapy is underused in patients with ulcerative colitis
48. Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II
49. Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary international expert panel (EPACT II)
50. P-090: Use of thiopurines in Swiss pediatric IBD patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.